Purpose: To study the dosimetric characteristics of amorphous silicon Electronic Portal Imaging Device EPID and 2D array detector for dose verification of radiotherapy treatment plans, and the quality assurance QA testing of IMRT was investigated. Materials and methods: All measurements were done with Varian IX linear accelerator, aSi-1000 EPID and 2D array detector. The dose linearity, reproducibility, output factors, dose rate, SDD and response with slap phantom thickness have been measured and compared against those measured by ion chamber. Results: The characteristics of EPID and 2D array: the response of EPID agreed with 2D array and ion chamber 0.6cc. EPID and 2D array showed short-term output reproducibility with SD = 0.1%. The dose rates of 2D array SD = ±0.7%, EPID = ±0.4% compared with a 0.6 cc SD = ±0.5%. Output factor measurements for the central chamber of the EPID and 2D array showed no considerable deviation from ion chamber measurements. Measurement of beam profiles with the EPID and 2D array matched very well with the ion chamber measurements in the water phantom. The EPID is more sensitive to lower energy photons by increasing solid water phantom thickness. The mean and standard deviation passing rates (γ %≤1 ) for film, 2D array and EPID for 30 IMRT fields of five patients were 95.93 ± 0.96%, 99.05 ± 0.24%, and 99.37 ± 0.12%, respectively. Conclusion: The study shows that EPID and 2D array are a reliable and accurate dosimeter and a useful tool for quality assurance. We found that the EPID was more accurate compared with both 2D array and ion chamber. The gamma criterion of 3%/3 mm is the most suitable criteria for IMRT plans of QA. 
Introduction
The quality assurance (QA) procedure in radiotherapy generally demands dose measurement as well as patient positioning check. In conventional techniques, the dosimetric verification is based on well-tried methods carried out mostly during treatment sessions [1] . The verification of radiotherapy treatment plans is a very important step in complex radiotherapy techniques because the primary goal of radiation therapy is to deliver doses of ionizing radiation to a target volume while minimizing the dose to critical organs and healthy tissues. Ionization chamber array has become the standard device for quality assurance measurements in modern radiotherapy. In particular, the possibility of producing complex fields and dose shaping using devices such as multi leaf collimators (MLCs) has improved conformal radiotherapy techniques and boosted the clinical implementation of intensity modulated radiotherapy (IMRT) [2] . The increased complexity of clinical treatments raises the need for more accurate dose verification systems and procedures. Spezi E. et al. (2005) [3] characterized of a 2D ion chamber array for the verification of radiotherapy treatments. Markovic M.et al. (2014) [4] evaluated the Octavius Detector 1000 is an accurate, precise, and reliable detector, very useful for the daily performance of the patient specific quality assurance of radiotherapy treatment plans. EPID and 2D array have become the standard devices for QA measurements in modern radiotherapy techniques such as IMRT [5] [6] . For clinical dosimetry, the precision of dose delivery using linear accelerators to a patient must be accurate to within ±2% [7] [8] .
Van Esch et al. (2004) [9] evaluated the portal dose prediction model using the algorithm for amorphous silicon (a-Si) detector measurement and tested it for clinical IMRT treatment fields. IMRT is advanced form of 3D conformal radiation therapy (3DCRT); it is a powerful tool for delivery of conformal dose distributions [10] . IMRT is used in MLCs to change the intensity of the beam delivered to the tumor. As leaf motions are controlled by a computer, the IMRT technique lends itself to automated treatment delivery, eliminating the need for re-entry into the room between fields. During treatment, the leaf positions are verified by the computer, ensuring better quality control than when using customized field shaping blocks. Therefore, treatment quality assurance is necessary to define the difference between calculated and actual dose distributions [11] [12]. The implementation of IMRT in external beam therapy imposes high demands on the measurement device and quality assurance. Generally, three-dimensional dose distributions obtained from a treatment planning system have to be verified by dosimetric means. Mainly a comparison of two-dimensional calculated and measured data in several coplanar planes is performed [13] [14] .
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The dose can be measured directly, after calibration of the ionization chamber array. Though their resolution is less, compared to that of films or EPIDs, good dosimetric agreement was noticed between films and 2D ionization chambers for verification of radiotherapy plans, as reported by Spezi et al. [3] . To verify IMRT dose distribution, two dimensional detectors are used 2D array chamber or EPID. The properties of the EPID and 2D array chamber for pre-treatment verification of IMRT should be studied [15] [16] . Portal dose prediction (PDP) algorithm is performed in Eclipse treatment planning system (TPS) to test IMRT clinical treatment fields. The complexity of treatment needs more accurate dose verification systems and comprehensive procedures reports of QA in radiotherapy treatment planning [17] [18] [19] . Availability of new detectors with improved characteristics, better treatment calculation algorithms, modern treatment delivery machines and modes of delivery, made possible to improve on the conventional QA standards. The validity of aSi1000 EPID, 2D array detectors, and 3D verification systems as an ideal dosimeter for IMRT patient-specific QA [20] [21] .
The gamma index (GI) evaluation used to evaluate measured distributions in detector systems against the dose distribution predicted by treatment planning system. The Gamma index (GI) results of each plan were recorded for the passing criteria, and evaluated 3% DD, 3 mm DTA criteria for passing result by using EPID and 2D array detector, calculated the mean and Standard Deviations (SD) for each plan [9] .
This study was carried out to evaluate the dosimetric characteristics performance of EPID and 2D array for IMRT dose verification. To quantify the performance of the device, some of the basic dosimetry tests were carried out and also some of the tests were compared with the ionization chamber measurements. The basic tests included linearity, reproducibility, output factors dependency, dose rate dependency, and sensitivity for photon beams. The measurements carried out by the 2D array and EPID devices for verification of IMRT plans are also presented, and the same was compared with the film dosimetry measurements. All measurements were performed on amorphous silicon aSi-1000 EPID, 2D
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array 1500, waterproof chamber and IX accelerator (Varian) with nominal 6 and 18 MV energy photon beams. In this process a fixed pulse rate of 300 MU min −1 is used which the pulse rate used in clinical practice.
EBID, 2D Array Detector and QA Characterization
The properties of 2D array and electronic portal imaging device are verified in 
IMRT Dose Distribution Verification
In this study, IMRT QA with film, 2D array and EPID were used in the gamma index method to compare calculated TPS dose with measured dose, using 3% 3 mm gamma criteria. The traditional method of QA for IMRT was 2Dimensional testing using film (Kodak X-OMAT). The dose was measured at source to axis distance (SAD) of 100 cm, with the film located at 10 cm depth of slab phantom and a gantry angle of 0˚. Similar to film QA, the dose is measured at the standard measurement of setup for the 2D array at a gantry angle of 0˚. For EPID, SAD was set at 100 cm and at a gantry angle of 0˚. Measurement was done by EPID without phantom and EPID dedicated software (Eclipse, Ver. 8.9, Varian Medical System, and USA) was used to verify dose delivery after the beam measurement. IMRT was used for three (two males and one female) head and neck (H&N) plans, one male cervical spine and one male pelvises were selected to evaluate the mean and standard deviations (SD) of gamma index. The Gamma evaluations (DD and DTA) of measured dose against TPS calculated doses were performed for 25 IMRT cases (177 Fields). All the cases were planned in Eclipse treatment planning system and the QA plans for absolute point dose measurements, portal dosimetry, and 2D array were created for the TPS calculated planar dose distributions. The calculated and measured dose for each plan was compared on the basis of 3% 3 mm gamma criteria (DD and DTA). For the portal dosimetry, area gamma > 1%, average gamma, and maximum gamma were measured and tabulated. For the 2D array, the percentage of the pixels passed the acceptance criteria 3% 3 mm were calculated and tabulated. The mean and
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standard deviation for all the gamma parameters were calculated and compared.
The criteria validity accepted as section with gamma value γ %≤1 = 95%. Gamma parameters, γ max , γ avg and γ %≤1 were estimated for each field and calculated the mean and standard deviations (SD).
Results and Discussion

EBID, 2D Array Detector and QA Characterization
The characteristics of EPID and 2D array detectors have been investigated for periodic QA applications. Study verification of characteristics linearity, Reproducibility, dose rate, Field size, SSD, and response with slap phantom thickness response for both 2D array detector and EPID. . EPID and 2D array, the irradiation was repeated ten times using energy 6 MV over a period of short-term.
variation from chamber to chamber was ±1%. The EPID and 2D array demonstrates excellent short-term output reproducibility with a maximum standard deviation of 0.1%. were placed between the source and the detectors (EPID and 2D array). At each phantom thickness, both detectors were exposed at the same radiation conditions. Both the EPID and 2D array signals were acquired on the central axis, and the data for each detector was normalized to those when there was no absorbing material (thickness = zero). By increasing the solid water thickness, the EPID was more sensitive to lower energy photons, its response decreased more rapidly than the 2D array as a function of attenuator thickness.
Both the detector system showed good response for IMRT patient specific QA.
The EPID field verification could be done very effectively with an excellent spatial resolution. The disadvantages of the 2D array system are: the low resolution of the detectors, the time taken to set up the detectors, phantom and connect to the external computer system with analysis software. Syamkumar S. A. et al.
(2012) [2] reported, the 2D array provides an overall accuracy when compared with single ionization chamber measurements for static and rotational delivery.
Moreover, the dose calibration for the 2D array is easy and stable. 2D array and EPID are the tool for the quality assurance and the verification of radiotherapy plans.
IMRT Dose Distribution Verification
The Dose was calculated using TPS compared with dose measured by the dosimetric tools based on gamma evaluation (3%/3 mm). Table 1 shows the mean passing rates of gamma index, for the treatment fields of each patient using film, Table 1 . Mean passing rates based on the gamma index method for the treatment fields of each patient using film, 2D array, and electronic portal imaging device (EPID). of five patients were 95.93% ± 0.96%, 99.05% ± 0.24%, and 99.37% ± 0.12%, respectively. All acceptable passing rate of 95%, these tools showed some differences in measuring the same beam, with the gamma index being much lower for film than for the other tools. This comparison of gamma indices for film, 2D array, and EPID showed differences in dose distribution when using various dosimetric tools to carry out the QA for the same patients IMRT, results of QA dependency on dosimetric tools. We found that the EPID was more accurate compared with both 2D array and film.
A dosimetric IMRT field verification of 177 IMRT fields was carried out with 2D array detector by comparing the measured dose distribution to portal dosimetry measurement and TPS calculations. The results of gamma evaluation for 25 cases were tabulated as shown in the Table 2 , the data of 3% DD, and 3 mm DTA passing criteria of dose distribution using portal dosimetry and 2D array detector of various tumours. The mean and standard deviation (SD) of γ %≤1 , γ max and γ avg estimated from all fields of each IMRT plan, using EPID and 2D array detector, PDP predicted and EPID measured photon dose distribution corresponded with mean ± SD value for γ %≤1 = 99.01% ± 0.74%, γ max = 2.10% ± 0.57%, and γ avg = 0.23% ± 0.04%, respectively. Independent verification of the planned dose from the same IMRT fields using 2D array detector also resulted in comparable values of γ %≤1 = 98.06% ± 0.75%, γ max = 1.66% ± 0.45% and γ avg = 0.27% ± 0.04%.
Studies of dosimetric characteristics are essential before using at all dosimetric tools for the clinical purpose. At the present time portal dosimetry and 2D array detector verification systems are adopted for the patient specific QA due to excellent dosimetric characteristics and easiness to use. Dosimetric properties of aSi1000 EPID and 2D array system proved its worth over film and other dosi- these plans agreed to within ±5% acceptability criteria of the dose calculated by the planning system and the chamber measured dose.
Conclusion
The results showed that both of 2D array and EPID can be used in patient specific QA measurements for IMRT. It is a useful tool for the quality assurance and the verification of radiotherapy plans. The 2D array provides an overall accuracy when compared with single ionization chamber measurements for IMRT delivery. Moreover, the dose calibration for the 2D array is easy and stable. But EPID is more accurate dosimeter and a useful tool for quality assurance. The EPID of IMRT patient specific QA is great potential for saving time and for the verification of individual IMRT fields. The disadvantages of the 2D array system are: the low resolution of the detectors, the time taken to set up the detectors, phantom and connect to the external computer system with analysis software.
The results showed that the gamma criterion of 3%/3 mm is the most suitable criteria for IMRT plans QA. The result shows a very good agreement between measured dose and calculated dose of the TPS, proving that our treatment planning using patient specific IMRT QA is the sufficient practice for IMRT treatment.
